Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
asengeprast (FT011) / Certa Therap, OccuRx
NCT04647890 / 2020-005116-21: Effects of FT011 in Systemic Sclerosis	Completed	2	30	Europe, RoW	FT011, Placebo	Certa Therapeutics	Scleroderma, Systemic, Scleroderma, Diffuse, Sclerosis, Systemic	10/22	11/22